Institute of Medicine Issues New Report on the Use of “omics”

The Institute of Medicine (IOM) recently issued a new report on the use genomics, proteomics, and other areas of molecular biosciences, often broadly referred to “omics.” To maximize omics-based research, the IOM recommends a detailed process to evaluate whether the data and computational steps underlying such tests are ready for usage in clinical trials. The new report outlines responsibilities and best practices for researchers and institutions.

According to the IOM committee charged with issuing the report, it is their intention to provide transparency and offer a pathway of translating omics research discoveries into clinical tests and avoid the potential pitfalls at each stage.

The full-text of the IOM’s report can be read here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: